# US 2024/0400608 A1 · Synthesis of bicycle toxin conjugates, and intermediates thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0400608 A1
- Document ID: US20240400608A1
- Status: Published application
- Kind: A1
- Application number: 18/688,590
- Filed: 2022-09-02
- Published: 2024-12-05
- Earliest claimed: 2021-09-03
- Assignees: BricycleTx Limited
- Applicants: BricycleTx Limited
- Inventors: David Witty; Darren Limb; Byoung Joon Min; Liwen He; William J. Sanders; Ernest Obinna Nnanabu
- Web page: https://patentgrep.com/patent/US20240400608A1

## CPC

- C07K 1/026: {by fragment condensation in solution}
- C07K 5/0205: {containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof}
- A61K 47/64: Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers A61K47/65)
- C07K 1/24: by electrochemical means
- C07K 1/30: by precipitation
- C07K 14/43504: {from invertebrates}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to Bicycle toxin conjugates, methods for preparation, and methods of use for treating cancer.

## Claims

### Claim 1

A method of preparing a compound of formula I, or a salt thereof, comprising steps of 1) providing fragment F-2
or a salt thereof;
2) reacting fragment F-2 with fragment F-3
or a salt thereof, to form a compound of formula I
or a salt thereof; and
3) separating the compound of formula I, or a salt thereof, from reaction mixture by precipitation in a non-polar solvent,
wherein:
each of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, and R11 is independently hydrogen or an optionally substituted group selected from C1-6 aliphatic, a 3-8 membered saturated or partially unsaturated monocyclic carbocyclic ring, phenyl, an 8-10 membered bicyclic aromatic carbocyclic ring, a 4-8 membered saturated or partially unsaturated monocyclic heterocyclic ring having 1-2 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 5-6 membered monocyclic heteroaromatic ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-10 membered bicyclic heteroaromatic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur;
m is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or 15; and
n is 0, 1, or 2.

### Claim 2 (depends on 1)

The method of claim 1, wherein the step 1) reaction uses about 1 equivalent of fragment F-2.

### Claim 3 (depends on 1, 2)

The method of claim 1 or 2, wherein step 2) reaction is in a dipolar aprotic solvent.

### Claim 4 (depends on 3)

The method of claim 3, wherein the dipolar aprotic solvent is N,N-dimethylacetamide (DMA).

### Claim 5 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, wherein the non-polar solvent of step 3) is an ether.

### Claim 6 (depends on 5)

The method of claim 5, wherein the ether is methyl tert-butyl ether (MTBE).

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The method of any one of claims 1-6, further comprising purifying the compound of formula I, or a salt thereof, by column chromatography.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The method of any one of claims 1-7, wherein an impurity at RRT 0.93 is formed in less than about 5% relative area to a compound of formula I.

### Claim 9 (depends on 8)

The method of claim 8, wherein the impurity is less than about 2.5%.

### Claim 10 (depends on 9)

The method of claim 9, wherein the impurity is less than about 1%.

### Claim 11 (depends on 10)

The method of claim 10, wherein the impurity is less than about 0.5%.

### Claim 12 (depends on 11)

The method of claim 11, wherein the impurity is less than about 0.05%.

### Claim 13

A method of preparing fragment F-2, or a salt thereof, comprising steps of
1) providing fragment F-1
or a salt thereof;
2) reacting fragment F-1 with compound A
to form fragment F-2
or a salt thereof; and
3) separating fragment F-2, or a salt thereof, from reaction mixture by precipitation in a non-polar solvent,
wherein:
each of R10 and R11 is independently hydrogen or an optionally substituted group selected from C1-6 aliphatic, a 3-8 membered saturated or partially unsaturated monocyclic carbocyclic ring, phenyl, an 8-10 membered bicyclic aromatic carbocyclic ring, a 4-8 membered saturated or partially unsaturated monocyclic heterocyclic ring having 1-2 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 5-6 membered monocyclic heteroaromatic ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-10 membered bicyclic heteroaromatic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur; and
n is 0, 1, or 2.

### Claim 14 (depends on 13)

The method of claim 13, wherein step 2) reaction is in a dipolar aprotic solvent.

### Claim 15 (depends on 14)

The method of claim 14, wherein the dipolar aprotic solvent is N,N-dimethylacetamide (DMA).

### Claim 16 (depends on 13, 14, 15)

The method of any one of claims 13-15, wherein the non-polar solvent of step 3) is an ether.

### Claim 17 (depends on 16)

The method of claim 16, wherein the ether is methyl tert-butyl ether (MTBE).

### Claim 18 (depends on 13, 14, 15, 16, 17)

The method of any one of claims 13-17, further comprising purifying fragment F-2, or a salt thereof, by charging the reaction solution into an acidic saturated brine solution.

### Claim 19 (depends on 18)

The method of any one of claim 18, further comprising purifying fragment F-2, or a salt thereof, by column chromatography.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method of any one of claims 1-12, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, and R11 is independently an optionally substituted group selected from C1-6 aliphatic, a 3-8 membered saturated or partially unsaturated monocyclic carbocyclic ring, phenyl, an 8-10 membered bicyclic aromatic carbocyclic ring, a 4-8 membered saturated or partially unsaturated monocyclic heterocyclic ring having 1-2 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 5-6 membered monocyclic heteroaromatic ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-10 membered bicyclic heteroaromatic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur.

### Claim 21 (depends on 20)

The method of claim 20, wherein R1 is

### Claim 22 (depends on 20)

The method of claim 20, wherein R2 is

### Claim 23 (depends on 20)

The method of claim 20, wherein R3 is

### Claim 24 (depends on 20)

The method of claim 20, wherein R4 is

### Claim 25 (depends on 20)

The method of claim 20, wherein R5 is

### Claim 26 (depends on 20)

The method of claim 20, wherein R6 is

### Claim 27 (depends on 20)

The method of claim 20, wherein R7 is

### Claim 28 (depends on 20)

The method of claim 20, wherein R8 is

### Claim 29 (depends on 20)

The method of claim 20, wherein R9 is

### Claim 30 (depends on 20)

The method of claim 20, wherein R10 is

### Claim 31 (depends on 20)

The method of claim 20, wherein R11 is

### Claim 32 (depends on 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The method of any one of claims 20-31, wherein the compound of formula I is

### Claim 33 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method of any one of claims 1-12, wherein fragment F-3 is
or a salt thereof.

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method of any one of claims 1-12, wherein fragment F-2 is
or a salt thereof.

### Claim 35 (depends on 33)

The method of claim 33, wherein fragment F-3 is
or a salt thereof.

### Claim 36 (depends on 34)

The method of claim 34, wherein fragment F-2
or a salt thereof.

### Claim 37 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

The method of any one of claims 1-12 or 20-36, wherein the compound of formula I is BT8009, or a salt thereof.
